BD AutoShield Duo™ pen needle

Keep safety injections short and simple

Carousel Image
Loading
tabs dropdown arrow
About
false
true

Features and Benefits

  • Needle concealment

     

    An outer shield conceals the 5-mm single-use needle, so patients do not need to see it or feel intimidated by it.

     

  • Reduced IM injection risk

     

    By delivering subcutaneous injections, the 5-mm pen needle helps reduce the risk of intramuscular (IM) injections that can increase the risk of hypoglycemia in patients, regardless of their body mass index (BMI).1–3

     

  • Large barrel

     

     

    The pen needle features a large barrel for easy handling and attachment.

     

     

  • Red indicator band

    After users finish performing the injection and lift the pen needle away from the skin, the pen's inner shield automatically deploys and locks. A red indicator band then confirms that the shield is locked and the needle has been used.

  • Reduced IM injection risk

    By delivering subcutaneous injections, the 5-mm pen needle helps reduce the risk of intramuscular (IM) injections that can increase the risk of hypoglycemia in patients, regardless of their body mass index (BMI).1–3

     

  • Thin wall technology

    Our needles retain their extremely fine external dimensions but with a wider inner diameter, improving insulin flow rate and requiring less force.4

     

  • OSHA compliance

    The pen needle helps meet the OSHA requirement to evaluate safer devices as they become available.5 It is the only safety pen needle that passively conceals the needle in the front and back after use, reducing nurse exposure to the needle.

  • Rigorous testing

    The pen needle is rigorously tested for fit, function and dose accuracy.

  • Single-handed injection technique

    Because the BD AutoShield Duo™ pen needle does not require a pinch-up technique, the risk of needlestick injury during injection may be reduced.

Related Product

Resources
FAQ
false
true

Notes and References

* Children from 2 to 6 years old, extremely lean adults or people with loose skin may need to use a pinch-up technique.

† Users must avoid placing their fingers on either end of the pen needle shields.

 
  1. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
  2. Frid A, Hirsch L, Gaspar R, et. al. New injection recommendations for patients with diabetes. Diabetes Metab. 2010;36 Suppl 2:S3-S18.
  3. Karges B, Boehm BO, Karges W. Early hypoglycemia after accidental intramuscular injection of insulin glargine. Diabet Med. 2005;22(10):1444-1445.
  4. Aronson R, Gibney MA, Oza K, Bérubé J, Kassler-Taub K, Hirsch L. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence and other patient ratings. Clin Ther. 2013;35(7):923-933.
  5. Occupational Safety and Health Administration. Bloodborne pathogens. 29 CFR §1910.1030. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051.

Request a demo or get in touch with our sales representative

Sales Form
Please fill out the form and a sales representive will get in touch with you.

Capability

Product Line